Neos Therapeutics Nabs $24.1M

Grant Prairie-based Neos Therapeutics, a specialty pharmaceuticals firm developing time release medications, has now raised $24.1M in a funding round targeted at $50.0M, according to a filing by the firm this week. Source of the funding was not disclosed. The fundraising effort is being spearheaded by Salem Partners.